Search Header Logo
FDA Grants Emergency Approval To Pfizer-BioNTech COVID-19 Vaccine

FDA Grants Emergency Approval To Pfizer-BioNTech COVID-19 Vaccine

Assessment

Interactive Video

Health Sciences, Biology

University

Practice Problem

Hard

Created by

Wayground Content

FREE Resource

Pfizer's COVID-19 vaccine, the first to receive emergency approval in the US, uses mRNA technology to trigger an immune response. It requires two doses, 21 days apart, and is 95% effective. Distribution involves logistical challenges, including repurposing and unfrozen vaccines, and managing healthcare workers' schedules to avoid crowding and handle potential side effects. Hospitals are preparing to receive and administer vaccines, with plans to start vaccinations shortly after arrival.

Read more

2 questions

Show all answers

1.

OPEN ENDED QUESTION

3 mins • 1 pt

What logistical challenges are mentioned regarding the distribution of the vaccine?

Evaluate responses using AI:

OFF

2.

OPEN ENDED QUESTION

3 mins • 1 pt

What are some potential side effects of the vaccine mentioned in the text?

Evaluate responses using AI:

OFF

Access all questions and much more by creating a free account

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

Already have an account?